Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma
NCT01129167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1052
Last updated 2023-03-17
Summary
Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microscopic invasion is associated with recurrence of pancreatic cancer after pancreatic resection, such that even if the original cancer is surgically removed, microscopic areas of cancer often remain. Data on the patterns of local invasion by pancreatic cancer have not been published. In this study, The investigators hope to investigate the frequency of the various methods of local invasion of pancreatic adenocarcinoma. This would help the investigators better understand how pancreatic cancer spreads, and determine what cancers are not resectable.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Wendy K Chung, MD · Columbia University
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-15
- Primary Completion
- 2022-09-30
- Completion
- 2022-09-30
Countries
- United States
Study Locations
More Related Trials
-
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
NCT06941857 ·Status: RECRUITING ·Phase: PHASE2
-
Influence of Metastatic Sites on Survival Outcomes and Predictive Factors for Extended Survival in Metastatic Pancreatic Cancer a Retrospective Study
NCT07086352 ·Status: NOT_YET_RECRUITING
-
Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas
NCT06311032 ·Status: COMPLETED
-
Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy
NCT07243288 ·Status: ACTIVE_NOT_RECRUITING
-
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
NCT03257033 ·Status: RECRUITING ·Phase: PHASE3
-
Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?
NCT06921252 ·Status: COMPLETED
-
Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
NCT00126633 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas
NCT04617457 ·Status: RECRUITING ·Phase: PHASE2
-
Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery
NCT00601627 ·Status: COMPLETED ·Phase: PHASE2
-
Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
NCT03970252 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI
NCT05511116 ·Status: UNKNOWN
-
Circulating Tumor Cells in Operative Blood
NCT02150746 ·Status: COMPLETED
-
Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
NCT00003797 ·Status: UNKNOWN ·Phase: PHASE2
-
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
NCT01571024 ·Status: COMPLETED ·Phase: PHASE1
-
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
NCT00005926 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma
NCT05248750 ·Status: RECRUITING
-
First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI
NCT03693677 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
NCT01032057 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
NCT00003332 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
NCT00010088 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas
NCT00038701 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
NCT00303758 ·Status: COMPLETED ·Phase: PHASE3
-
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
NCT01102556 ·Status: RECRUITING
-
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
NCT04164602 ·Status: UNKNOWN
-
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT06595160 ·Status: RECRUITING